DOES SPIRONOLACTONE HAVE A SURVIVAL BENEFIT IN PATIENTS WITH ISOLATED RIGHT VENTRICULAR FAILURE SECONDARY TO SEVERE PULMONARY HYPERTENSION

Spironolactone is known to improve survival in patients with left ventricular failure. However, it is unclear whether it provides a survival benefit in patients with isolated right ventricular failure secondary to pulmonary hypertension (PH). We aimed to examine the effect of spironolactone on